physostigmine has been researched along with Carcinoma, Epidermoid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhuyan, BK; Buskirk, HH; Kuentzel, SL; Manak, RC; Moxley, TE; Neil, GL | 1 |
1 other study(ies) available for physostigmine and Carcinoma, Epidermoid
Article | Year |
---|---|
Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabine.
Topics: Animals; Antineoplastic Agents; Carboxylic Acids; Carcinoma, Squamous Cell; Cell Line; Cells, Cultured; Cycloparaffins; Cytarabine; Deamination; Delayed-Action Preparations; Depression, Chemical; DNA, Neoplasm; Half-Life; Haplorhini; Humans; Hydrolysis; In Vitro Techniques; Leukemia L1210; Mice; Neoplasm Proteins; Physostigmine; Plasma; RNA, Neoplasm; Tritium; Uridine | 1971 |